← Open Payments lookup

DANIEL HURLEY: Open Payments

NPI 1255739587 · FARMINGTON HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$881 in 46 payments from 23 companies in 2025. Trend: 2023 $609 · 2024 $774 · 2025 $881

Food & beverage: $881
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.4$106
Bausch Health US, LLC3$66
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$56
Novo Nordisk Inc3$55
GlaxoSmithKline, LLC.3$51
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$48
Teva Pharmaceuticals USA, Inc.2$48
PFIZER INC.3$48
Axsome Therapeutics, Inc.2$40
Sumitomo Pharma America, Inc.2$39

Products named: INGREZZA, XIFAXAN, TRELEGY ELLIPTA, CAPLYTA, AUSTEDO XR, APLENZIN, Auvelity, GEMTESA.

Industry payments across MI — which companies pay providers there.